USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Future Growth Potential Driven by Capabilities and Expertise in Vaccine Manufacturing
26-Nov-2021
Europe
Market Research
PC55-01-00-00-00
HC03475-EU-MT_26006
With this research service, Frost & Sullivan’s Healthcare and Life Sciences team provides critical insights into the European Union and UK COVID-19 vaccine and therapeutics market. The report analyzes COVID-19 vaccines and therapeutics in development and delves into supply chain considerations and requirements to manage distribution. Importantly, the study identifies actionable growth opportunities for industry participants. Like the United States, the European Union received criticism for vaccine nationalism, but it is taking steps to encourage global vaccine access. It has launched the Team Europe initiative for improving manufacturing and access to vaccines, medicines, and health technologies in Africa.
Initiatives such as the EU Digital Vaccination Passport and UK NHS COVID Pass app will help Europe in safe reopening and overcoming COVID-19 variants of concern to a certain extent. Although vaccinations are progressing at a fast pace, factors that will determine campaigns’ future course include political and religious situations, vaccine availability and access, and vaccine hesitancy specifically in younger population groups. The low vaccination rate in Central and Eastern Europe (CEE) is fueling another COVID-19 surge (especially because of the Delta variant) and causing a healthcare crisis in Bulgaria, Romania and Latvia.
Topics covered include:
• Analyses of COVID-19 vaccines and therapeutics
• Strategies of vaccine manufacturers to scale up their global manufacturing network
• COVID-19 vaccination rollouts
• The role of digital technology in the COVID-19 battle
• The Growth Opportunity Universe
Author: Surbhi Gupta
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives for the EU COVID-19 Vaccine and Therapeutics Market
Growth Opportunities Fuel the Growth Pipeline Engine™
Highlights
Regional Impact of COVID-19 Vaccinations
Scope of Analysis
Growth Drivers for Recovery from the COVID-19 Pandemic
Growth Restraints for Recovery from the COVID-19 Pandemic
COVID-19 Vaccine Pipeline Analysis
Overview of Key Authorized COVID-19 Vaccines Globally
Selected Vaccine Candidates in Phase III
Key Small Molecules in Late Stage of Development (Antivirals and Immunomodulators)
Key mAbs in Late Stage of Development
EU COVID-19 Therapeutics Snapshot
Pfizer/BioNTech Vaccines
Moderna
J&J
Oxford/AZ
Novavax
Capacity Secured
Distribution of COVID-19 Vaccine Doses by Manufacturer
Percentage of Adults Fully Vaccinated Against COVID-19
COVID-19 Vaccination Doses Administered in Selected Countries
Germany—Approaching the 70% First-dose Milestone
France—More than 70% of the Population Fully Vaccinated
Italy—Reached the 70% First-dose Milestone
UK—First European Country to Reach the 70% First-dose Milestone
Behind the Successful UK Rollout
DHL Express Hub and Gateway Model
Digital Technology Platforms Enabling Data Management, Vaccination, and Rebounding from COVID-19
EU COVID-19 Certificate/Health Pass
IBM Digital Health Pass
Growth Opportunity 1—Additional and Booster Doses for Waning Immunity and Emerging Virus Variants
Growth Opportunity 1—Additional and (continued)
Growth Opportunity 2—Strengthening Domestic Manufacturing for Leading Global Supply of COVID-19 Vaccine
Growth Opportunity 2—Strengthening Domestic Manufacturing for Leading Global Supply of COVID-19 Vaccine (continued)
Growth Opportunity 3—Global Standard Solution for Recognising and Verifying Individual Countries’ COVID-19 Health Pass
Growth Opportunity 3—Global Standard Solution for Recognising and Verifying Individual Countries’ COVID-19 Health Pass (continued)
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Surbhi Gupta |
| Industries | Healthcare |
| WIP Number | PC55-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9571-B1,9611-B1 |
EU COVID-19 Vaccine and Therapeutics Insights, Trends, and Growth Opportunities
$2,450.00
Special Price $1,837.50 save 25 %